[ad_1]
An AWS beat is “expected,” while a miss could stir up questions about the company’s positioning in the cloud, according to an analyst
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...